FeesSafety
Pluang+

Asimov and Emergent partner to develop Ebola antibodies using AI-driven cell line technology

Market News
16 Nov 2026, 23:01 WIB
GlobeNewsWire
View Source
Bullish
Asimov and Emergent partner to develop Ebola antibodies using AI-driven cell line technology

Asimov and Emergent Biosolutions have formed a partnership to develop cell lines for two monoclonal antibodies targeting Ebola. Emergent will use Asimov's CHO Edge System, which integrates AI-driven genetic design, to create high-titer cell lines aimed at advancing medical countermeasures against Ebola. This collaboration leverages Emergent's expertise in biodefense and Asimov's synthetic biology platform to accelerate the development of novel therapies that could enhance global health preparedness against biological threats. The partnership reflects ongoing efforts to innovate in the fight against serious infectious diseases like Ebola.

Asimov and Emergent Biosolutions' partnership for Ebola antibody development is presented here with Pluang's Health sector market data as of Nov 17, 2026 03:31 WIB. Of 150 priced Health-sector US stocks tradable on Pluang, 31 rose and 118 fell today. Notable movers include AMLX (Amylx Pharmaceuticals Inc) at USD 27.98 with a 1-day change of -7.63% and 100% sell order activity, NUWE (Nuwellis Inc) at USD 4.53 down 7.55%, and ACB (Aurora Cannabis Inc) at USD 4.60 down 6.88%.

More News

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney's fiscal Q4 report, due November 17, is expected to show strong growth with analysts forecasting over 50% earnings per share (EPS) growth and more than 12% revenue increase. Streaming revenue rose 11% last quarter with margins hitting double d...

Company Fundamentals
Bullish
2 hours ago
Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox has launched a new Australia realm on Amazon Web Services (AWS) in the Sydney region, providing Australian government agencies and enterprises a local option for managing DNS, DHCP, and IP address management (DDI) with enhanced security. Thi...

Market News
Bullish
2 hours ago
European Commission approves RASONQUE for metastatic pancreatic cancer treatment

European Commission approves RASONQUE for metastatic pancreatic cancer treatment

The European Commission has approved RASONQUE (daraxonrasib), the first broad RAS-targeted oral medicine for adults with metastatic pancreatic adenocarcinoma who have had prior systemic therapy. This approval covers patients with or without identifie...

Market News
Bullish
3 hours ago
SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE, a European leader in multi-technical services, has acquired Dutch company Duflex B.V. to enhance its industrial automation, machine building, and robotics capabilities. Duflex, with 26 employees and €8 million revenue in 2025, specializes in ta...

Company Fundamentals
Bullish
4 hours ago
Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel Développement SAS disclosed that it repurchased a total of 3,878 of its own shares between November 9 and November 13, 2026. The average purchase price during this period was approximately €34.67 per share. This buyback is part of an authorized...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App